Akero Therapeutics, Inc. (AKRO)

Akero Therapeutics Statistics

Total Valuation

AKRO has a market cap or net worth of $3.86 billion. The enterprise value is $2.76 billion.

Market Cap	3.86B
Enterprise Value	2.76B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

AKRO has 79.72 million shares outstanding. The number of shares has increased by 29.31% in one year.

Current Share Class	79.72M
Shares Outstanding	79.72M
Shares Change (YoY)	+29.31%
Shares Change (QoQ)	+11.45%
Owned by Insiders (%)	1.30%
Owned by Institutions (%)	92.93%
Float	66.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.56
P/TBV Ratio	3.56
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.80, with a Debt / Equity ratio of 0.03.

Current Ratio	16.80
Quick Ratio	16.17
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-63.41

Financial Efficiency

Return on equity (ROE) is -27.92% and return on invested capital (ROIC) is -19.13%.

Return on Equity (ROE)	-27.92%
Return on Assets (ROA)	-18.52%
Return on Invested Capital (ROIC)	-19.13%
Return on Capital Employed (ROCE)	-27.51%
Revenue Per Employee	n/a
Profits Per Employee	-$4.28M
Employee Count	63
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +80.96% in the last 52 weeks. The beta is -0.28, so AKRO's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	+80.96%
50-Day Moving Average	51.81
200-Day Moving Average	41.08
Relative Strength Index (RSI)	39.95
Average Volume (20 Days)	915,677

Short Selling Information

The latest short interest is 8.16 million, so 10.24% of the outstanding shares have been sold short.

Short Interest	8.16M
Short Previous Month	9.06M
Short % of Shares Out	10.24%
Short % of Float	12.36%
Short Ratio (days to cover)	5.56

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-306.35M
Pretax Income	-204.18M
Net Income	-269.44M
EBITDA	-306.33M
EBIT	-306.35M
Earnings Per Share (EPS)	-$3.74

Balance Sheet

The company has $686.29 million in cash and $36.23 million in debt, giving a net cash position of $1.09 billion or $13.70 per share.

Cash & Cash Equivalents	686.29M
Total Debt	36.23M
Net Cash	1.09B
Net Cash Per Share	$13.70
Equity (Book Value)	1.08B
Book Value Per Share	13.60
Working Capital	670.71M

Cash Flow

In the last 12 months, operating cash flow was -$262.63 million and capital expenditures -$999,000, giving a free cash flow of -$263.63 million.

Operating Cash Flow	-262.63M
Capital Expenditures	-999,000
Free Cash Flow	-263.63M
FCF Per Share	-$3.31

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AKRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.31%
Shareholder Yield	n/a
Earnings Yield	-6.99%
FCF Yield	-6.84%

Analyst Forecast

The average price target for AKRO is $82.50, which is 70.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$82.50
Price Target Difference	70.56%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2